Rheumatoid Arthritis
Tapering csDMARDs in RA remission fails to achieve non-inferiority vs. stable dose
Patients in rheumatoid arthritis remission who tapered off conventional synthetic disease-modifying antirheumatic drugs had higher risks for flares, with two methods failing to reach non-inferiority vs. stable dosage, according to data.
RheumMadness ’24: Pinpointing the most ‘practically perfect’ pearls for clinical use
The power of biologics in treating rheumatoid arthritis bested the benefits of the Mediterranean diet in this year’s RheumMadness tournament, coming out ahead as the most “practically perfect” nugget to carry forward into practice.
Q&A: No ‘one-size-fits-all’ approach to diet in rheumatoid arthritis
Patients with rheumatoid arthritis may be able to tame their disease progression and inflammation by adopting elements of the Mediterranean diet such as lowering sugar intake and incorporating protein in the form of fish or plant-based sources.
Higher tofacitinib dose raises pulmonary embolism, VTE risks in rheumatoid arthritis
Patients receiving daily tofacitinib doses of 10 mg for rheumatoid arthritis demonstrate an increased risk for venous thromboembolism and pulmonary embolism, compared with those taking TNF inhibitors, according to data.
Amjevita leads Humira biosimilars in clinician comfort as rheumatologists remain wary
Only half of rheumatologists are “extremely comfortable” prescribing the Humira biosimilar Amjevita, while just 16% can say the same for all other adalimumab biosimilars combined, according to a market analysis from Spherix Global Insights.
First-trimester hydroxychloroquine use adds no significant risk for birth defects
Hydroxychloroquine use for systemic lupus erythematosus or rheumatoid arthritis in the first trimester of pregnancy does not significantly increase the risk for major congenital malformations, according to data published in Rheumatology.
Ancient skeleton with RA may suggest ‘we’ve been dealing with these diseases forever’
Archaeologists in Egypt recently discovered evidence of an ancient case of rheumatoid arthritis, potentially filling in the timeline of humanity’s relationship with autoimmune disease.
Risk for post-acute sequelae of COVID-19 down among patients with SARDs
Since the beginning of the COVID-19 pandemic, there has been a “significant decrease” in the risk for post-acute sequelae of COVID-19 among patients with rheumatic diseases, according to data published in The Journal of Rheumatology.
Combating high RA prevalence in Navajo Nation requires ‘position of humble inquiry’
Compared with the general U.S. population, Navajo Nation in Arizona, New Mexico and Utah has five times the prevalence of rheumatoid arthritis.
Q&A: Rheumatologists encouraged to address gender disparities in RA
Although it is still unclear why gender differences exist in rheumatoid arthritis, it is known that the disease is more prevalent among and tends to be more painful for women.